Cognito Therapeutics
Cambridge, Massachusetts, United States
Cognito Therapeutics is a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders including Alzheimer’s disease. The company’s licensed proprietary neuromodulation platform technology is a non-invasive, neurostimulation therapy utilizing visual and auditory stimulation to treat neurodegenerative diseases.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2016
- Website
- www.cognitotx.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Cognito Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now